ABOUT US

FOUNDED AS A SPIN-OUT FROM THE NATIONAL UNIVERSITY OF SINGAPORE (NUS), INEX INNOVATE IS ASIA'S FIRST HEALTHCARE TECHNOLOGY COMPANY FOR WOMEN.

The Company focuses on Innovations in Molecular Diagnostics— ideating, developing and translating new technologies to address unmet needs in women’s and fetal health. The Company’s vision is to make its technologies accessible to women across Asia and around the world, and to give women and mothers greater certainty and confidence in diagnostic testing by pushing the boundaries of science.

INEX currently has in excess of forty-seven key patents, nine trademarks, and exclusive licences for Next Generation Sequencing Technology and Non Invasive Prenatal Testing from Global Centres of Medical Excellence. The Company is backed by institutional and government shareholders including Enterprise Singapore, Genting Berhad, Zicom MedTacc and PriceWaterhouseCoopers.

FOUNDERS

A/PROFESSOR MAHESH CHOOLANI

MBBS, FRCOG, FRANZCOG, MMED, FAMS (OG), FAMS (CS), PhD

Senior Consultant, High Risk Pregnancy Unit
NUH, Director of Research, Obstetrics & Gynaecology, NUS

PROF. ARIJIT BISWAS

MBBS, MD, FRCOG, FAMS

Senior Consultant (Maternal-Fetal Medicine Division),

Professor & Clinical Director, Department of Obstetrics and Gynaecology,

NUHS  Past President, College of O&G Singapore    

DR. SIDNEY YEE PHD

BSc, PhD

Senior Advisor
A*Star A*ccelerate 

DR. KHALIL RAZVI

MBBCh BAO, LRCPI. LRCSI, MMED (O&G), FAMS, FRCOG

Consultant Gynaecological Oncologist,
Southend University Hospital NHS Foundation Trust

 

BOARD OF DIRECTORS

CHAIRMAN

PROF. STEVEN MYINT

Prof. Steven Myint is a physician with broad experience at board executive level in academia and the biopharmaceutical sector, with an international reputation in infectious disease research and vaccine development. After his own first university spinout in 1995, he has been involved in the development of over 20 SME’s in life sciences and created over $1billion value for shareholders.

 

He holds Non-Executive Directorships with several organizations in the public and private sectors. Prof Myint is also a Senior Fellow and Strategic Advisor to A*STAR and on the Board of the Medical School Research Board at National Technological University of Singapore.

 

Prof Myint is the Founding Partner at Innovatum, as well as formerly Chairman of Green Signal Biopharma. He was a Professor and Dean of Medicine & Health at the University of Survey and Professor of Microbiology & Immunology at the University of Leicester. He has been a Global Medical Director at GlaxoSmithKline and Senior Vice-President for R&D/Chief Medical Officer at BTG International.

CHIEF EXECUTIVE OFFICER

KANE BLACK

Mr. Black began his career with Tokyo Stock Exchange (Jasdaq) listed semiconductor trading company Adtec Corporation K.K and later become Director of International Markets based in London U.K. 

 

In 2005 he was instrumental in the takeover of Adtec Corporation by Tokyo Stock Exchange listed electronic component manufacturer and trading conglomerate, Shinden Hightex Corporation.

 

As a seasoned entrepreneur Mr. Black has enjoyed an extensive and diverse international career as Director and Financial Advisor to numerous firms in the trading, construction, investment management and biotechnology sectors in Australia, Europe, the  Middle East and across Asia.

            

In 2012 he co – founded Nova Satra Health with the aim to identify, research, develop and commercialise cutting edge technology in the healthcare spectrum.

 

Mr. Black obtained a Bachelor of International Business from Bond University, Australia.

CHIEF SCIENTIFIC OFFICER

PROF. MAHESH CHOOLANI

Associate Professor Choolani is the principle Founder of INEX. He served as Chairman since the company’s inception in 2006 and was a key driver in the successful development of INEX from a small biotech start-up to a leading women’s health diagnostic company. In February 2014, he continued as Founder Director and manages the strategic and scientific objectives of the company.

 

A/Professor Choolani leads the High-Risk Pregnancy Unit of Maternal-Fetal Medicine Division at the National University Hospital (NUH), where he and his team were instrumental in the development of the breakthrough FlashFISH™ technology. FlashFISH™ is a rapid diagnostic test performed during amniocentesis that can detect Down syndrome in unborn babies within three hours. The technology put Singapore on the world map as being the first country to offer Same-Day Prenatal Diagnosis.

 

A/Professor Choolani received the Benjamin Henry Sheares’ Memorial Lecture Award in 2010 for his outstanding work in Obstetrics and Gynaecology. He has also been awarded the National Medical Research Council (NMRC) Clinician Scientist award for his outstanding contribution to research.

 

A/Professor Choolani has published over 100 articles and abstracts in notable journals and currently chairs the National University of Singapore’s Leadership in Academic Medicine Clinician Scientist Unit and the National Healthcare Group’s Clinician Leadership Research programme.

DIRECTOR

DR. SIDNEY YEE

As the founding Executive Director of INEX, Dr Sidney Yee led the company through a series of key strategic partnerships, resulting in licensing collaborations for iGene. She was also actively involved in the development of OvaCis, an innovative point of care kit for the detection of Ovarian Cancer.

 

Dr Sidney Yee is the founding CEO of Singapore’s Diagnostics Development Hub, as well as the Senior Adviser of A*STAR’s commercialisation arm - A*ccelerate . She has over 20 years of experience in a career that spans research, investments, operations, management and entrepreneurship development.

 

As a serial entrepreneur, Dr Sidney Yee has been actively involved in technology innovations translation and start-ups. Dr Sidney Yee is currently a non-executive Director of INEX.

DIRECTOR

KONG HAN TAN

Mr. Tan is the President and Chief Operating Officer of Malaysian conglomerate Genting Berhad and Chief Executive of Genting Plantations Berhad. Mr. Tan has extensive experience in investment banking, leisure, gaming, real estate and medical technologies.

 

He is also a director of Singapore based Alzheimer’s research company TauRx Pharmaceuticals, U.K Based next generation sequencing company DNAe Group and U.S based Elevance Renewable Sciences amongst others. He was called to the English Bar (Lincoln’s Inn) in 1989 and the Malaysian Bar in 1990.  

DIRECTOR

KOK HWEE SIM

Mr Sim is the Group Executive Director of Zicom Group Limited, Managing Director of iPtec Pte Ltd, and Chief Executive Officer of Zicom MedTacc Pte Ltd, a company focusing on investments and acceleration of early stage medical technologies companies. Both companies are supported by SPRING Singapore. His directorships in medtech companies include Biobot Surgical Pte Ltd, a spinoff from SingHealth and NTU that has developed a robotic platform for performing transperineal prostate biopsy; and Curiox Biosystems Pte Ltd, a spinoff from A*Star. 

 

Mr. Sim graduated with a Bachelor in Industrial and Operations Engineering (Magna Cum Laude) from the University of Michigan, Ann Arbor, USA and a Masters in Financial Engineering from Columbia University, New York, USA.

 
 

MANAGEMENT TEAM

CHIEF EXECUTIVE OFFICER

KANE BLACK

Mr. Black began his career with Tokyo Stock Exchange (Jasdaq) listed semiconductor trading company Adtec Corporation K.K and later become Director of International Markets based in London U.K. 

 

In 2005 he was instrumental in the takeover of Adtec Corporation by Tokyo Stock Exchange listed electronic component manufacturer and trading conglomerate, Shinden Hightex Corporation.

 

As a seasoned entrepreneur Mr. Black has enjoyed an extensive and diverse international career as Director and Financial Advisor to numerous firms in the trading, construction, investment management and biotechnology sectors in Australia, Europe, the  Middle East and across Asia.

            

In 2012 he co – founded Nova Satra Health with the aim to identify, research, develop and commercialise cutting edge technology in the healthcare spectrum.

 

Mr. Black obtained a Bachelor of International Business from Bond University, Australia.

CHIEF OPERATING OFFICER

JUNQUAN HUANG

Mr Huang joined INEX Innovate as Chief Operating Officer and is responsible for overseeing the operations of the company. 

 

Mr Huang has been in the biomedical industry since 2006, beginning his career as part of the human islet isolation program at St. Vincent’s Institute in Australia. Since then, Mr Huang has worked in Health Sciences Authority (HSA) and Agency for Science, Technology and Research (A*STAR).

 

In 2011, Mr Huang joined Biolidics Ltd (formerly known as Clearbridge Biomedics Pte Ltd) where he held several positions that culminated in his appointment as Chief Operating Officer. He was instrumental in leading the company's product development and commercialization of cancer diagnostic devices. He also assisted the company’s IPO in the Singapore Stock Exchange in 2018.

 

Mr. Huang obtained a Bachelor of Biomedical Science and Bachelor of Science (Degree with Honours) from the University of Melbourne, Australia. 

LABORATORY DIRECTOR

DR. SHERRY HO

Dr. Sherry Ho pursued her PhD in Molecular Diagnostics from the Department of Obstetrics & Gynaecology, National University of Singapore after a 4-year stint as Medical Technologist in Cytogenetics, Parkway Laboratory Pte Ltd.

 

She developed a strong interest and expertise in women’s healthcare, in particular, prenatal testing. Her achievements include several scientific awards in various conferences including a Young Scientist Award in Non-Invasive Prenatal Testing (NIPT), as well as two patents in the field. She was a Senior Postdoctoral Fellow for 7 years in a reference molecular diagnostic laboratory in the National University Hospital where she developed and validated several new tests for routine testing. She is also a trained CAP inspector and is lending her expertise in quality assurance within iGene Laboratory.

VP, RESEARCH & DEVELOPMENT

DR. CHIA PIN CHANG 

Dr. Chia-Pin Chang leads technical development and collaborator activities in INEX.  Before joining INEX, Dr. Chang was a Principal Investigator in Agency of Science and Research (A*STAR), Singapore, where his research interests include developing biochemical sensors and in-vitro diagnostics (IVD) devices for human disease detection. Several of his works have been licensed to industry partners for commercialization.

 

Dr. Chang holds a Bachelor of Science degree in Chemistry and a Doctor of Science degree in Computer Engineering from The George Washington University, Washington DC, USA.

SCIENTIFIC ADVISORY BOARD

PROF. RICHARD CHOY PH.D.

FIBMS, reg MT(HKMLTB)

Dr. Richard Choy brings more than 18 years of medical genetics, lab diagnostics test accreditations, business development and commercial operation in clinical laboratory services. He is an Associate Professor at Dept. of O&G, The Chinese University of Hong Kong (CUHK). Founded the CUHK Prenatal Genetic Diagnosis Centre and Pre-implanataion Genetic Laboratory (now #1 in Asia in microarray-based prenatal testing) and established the NATA-accredited  and CAP-accredited molecular and cytogenetics diagnostics laboratories. 

 

Prof Choy is experienced in implementing a broad range of molecular diagnostic tests including cytogenetics, NIPT, CMA and  low-pass whole genome sequencing analysis for Prenatal Diagnosis and Pre-implantation genetic testing. He is a board member of the Hong Kong Society of Medical Genetics and holds the Pre-implantation Genetic Diagnosis License in Hong Kong.

DR. KHALIL RAZVI

MBBCh BAO, LRCPI. LRCSI, MMED (O&G), FAMS, FRCOG

Dr. Khalil Razvi is a consultant gynaecological oncologist at Southend University Hospital NHS Foundation Trust. He has held leadership and administrative roles in the NHS including Clinical Director for the Obstetrics & Gynaecology department and Director for Women & Children. He is the lead Colposcopist in Southend Hospital and has led the Gynaecological Oncology service for South Essex.

 

He is actively involved in research with over 30 peer reviewed publications and over 50 conference publications. He is a co-inventor in 2 international patents for research into rapid diagnosis of fetal conditions and ovarian cancer. His main research interest is in Ovarian Cancer Diagnostics and Enhanced Recovery following major gynaecological surgery. He is currently involved in novel research using opto-magnetic imaging spectroscopy for cancer diagnostics.

 

Dr Razvi is a leading advocate in raising awareness of gynaecological cancers and has worked closely with ovarian cancer charities in the UK (Target Ovarian Cancer, Ovarian Cancer Action). He has also co-founded a gynaecological cancer charity in Essex called COPES (Cervical Ovarian Perineal Endometrial Support) which currently provides support for women who have gynaecological cancers as well as their families.

 

He mentors junior doctors during training especially in the performance of gynaecological surgery. He is a faculty member of the Anatomy of Complications Workshop in Singapore which trains surgeons in the prevention and management of surgical complications.

 

He is active in teaching and is an examiner for the MBBS exam in Queen Mary, University of London. He was previously an examiner for the National University of Singapore (MBBS, MMed exams) as well as the Royal Australian and New Zealand College of Obstetricians & Gynaecologists (MRANZCOG).

PROF. ARIJIT BISWAS

MBBS, MD, FRCOG, FAMS

Professor Arijit Biswas obtained his basic MBBS degree from Calcutta University, India where he was awarded the Gold Medal in aggregate as well as in Obstetrics & Gynaecology and Pathology. He started his postgraduate training in Obstetrics & Gynaecology at All India Institute of Medical Sciences (AIIMS), India in 1981 and continued further advanced specialist training in UK from 1987. He obtained his MD in 1986 and MRCOG (UK) in 1989. He obtained the FAMS in 1999 and became a Fellow of the Royal College in UK (FRCOG) in 2001.

 

His current practice at the NUH includes all areas of general obstetrics & gynaecology, heading the Fetal Care Centre in the hospital. His special interest is in the areas of prenatal diagnosis, antenatal ultrasound and high-risk pregnancies. He headed the Maternal-Fetal Medicine division of the department for 24 years from 1992 till 2016 and was also the President of College of Obstetricians & Gynaecologists Singapore (COGS) from 2015 till May 2017. Prof Biswas is currently the Chairman of Residency Advisory Committee, Ministry of Health, Singapore and the Clinical Director of the department in NUHS. 

 

He was awarded National Outstanding Clinician Award 2017 by the Ministry of Health to recognise his contributions for innovations in healthcare, patient safety, clinical quality, biomedical research as well as training and education of clinicians

DR. SAFEDIN “SAJO” BEQAJ

PHD, HCLD, CC (ABB)

Dr. Sajo Beqaj is board certified in molecular pathology and is a board certified clinical consultant. He has been practicing as a laboratory director since 2005. 

He received his PhD in pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003. He continued his career as a Research Assistant Professor at Children’s Memorial Hospital and Northwestern University, Chicago, Illinois until 2005 when he joined Path Group Labs, Nashville, Tennessee as Laboratory Director in molecular diagnostics. In 2008 he joined DCL Medical Laboratories as Laboratory Director for Clinical Pathology where he was responsible for clinical laboratory operations and technical operations including development and implementation of new tests and technologies.

 

Although he is a board certified high-complexity laboratory director and oversees all clinical pathology operations, his field of expertise is in molecular diagnostics and genetic testing. He has served as a teacher assistant at pathology department at Wayne State University, Detroit, Michigan, visiting professor of molecular diagnostics at Tennessee State University, Nashville, Tennessee; and as an adjunct professor of anatomy and physiology at Nashville State Community College, Nashville, Tennessee.

 

Dr. Beqaj has published more than 20 medical textbook chapters and journal articles. In addition, he has presented various scientific clinical abstracts and has conducted clinical trials for several well-known pharmaceutical and diagnostic companies. 

He is a member of numerous medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees.

 
INEX INNOVATE PTE. LTD

1 Science Park Road

#04-10 The Capricorn

Singapore 117528

CALL  +65 6773 0698

FAX   +65 6873 0240

© 2020 INEX INNOVATE PTE LTD